News

CEO John Schneider presented at Nordic Life Science Days in Stockholm, Sweden on the economic evaluation of pharmaceutical drugs, medical devices, and diagnostics.

CEO John Schneider presented at Nordic Life Science Days in Stockholm, Sweden on the Economic Evaluation of pharmaceutical drugs, medical devices, and diagnostics. Nordic Life Science Days attracts leading decision makers from the Life Science sector, not only from biotech, pharma and medtech but also from finances, research, policy and regulatory authorities. Click here to view […]

Avalon Health Economics will be attending Nordic Life Science Days 2014, Stockholm, Sweden, September 7-9

Avalon Health Economics will be attending Nordic Life Science Days 2014, Stockholm, Sweden, September 7-9. Avalon will present “Establishing the Value of New Drugs, Devices & Diagnostics” (See Presentation). The NLSD is the largest life sciences meeting held in the Nordic region, and will include representatives from pharmaceutical companies, medical device makers, diagnostics companies, and investors. […]

Noemi Kiss and Azal Ahmadi join Avalon Health Economics

Noemi Kiss is a Senior Health Economist with Avalon. She recently earned her MSc in Health Economics from the University of York (United Kingdom). Prior to York, Ms. Kiss was a Health Economist at Oxford Outcomes, Ltd (and Oxford’s parent company ICON plc), from 2010-13. Click here to read her biosketch. In addition to her […]

James Robinson joins Avalon Health Economics as a Director

James Robinson joins Avalon Health Economics as a Director. Jamie is the Leonard D. Schaeffer Professor of Health Economics and Director of the Berkeley Center for Health Technology (BCHT) at the University of California at Berkeley. In addition to his role as Director at Avalon Health Economics, his professional activities include his roles as Senior […]

Avalon at ISPOR: John Schneider and Cara Scheibling will be attending the annual meeting of the International Society of Pharmacoeconomics and Outcomes Research in Montreal next week, 6/1-6/4

Avalon at ISPOR: John Schneider and Cara Scheibling will be attending the annual meeting of the International Society of Pharmacoeconomics and Outcomes Research in Montreal next week, June 1 through June 4. The title of this year’s meeting is “Examining the Role of Big Data in Health Care Decision Making.” If you’d like to meet, let […]

Avalon will be attending and presenting at the EuroMedtech conference in Linz, Austria, May 7-8. The topic will be on economic evaluation of devices and diagnostics through the product lifecycle

Avalon will be attending and presenting at the 6th Annual EuroMedtech conference in Linz, Austria, May 7-8. The topic will be on economic evaluation of devices and diagnostics through the product lifecycle. Economic evaluations of new devices and diagnostics should begin early, and should be adjusted and revised throughout the product lifecycle as better data […]

Michael J. Lacey, MSc, has joined Avalon Health Economics as a Senior Consultant focusing on Economic Modelling & Value Strategy

Michael J. Lacey, MSc, has joined Avalon Health Economics as a Senior Consultant focusing on Economic Modelling & Value Strategy. He also works as an independent health economics consultant. He has over 15 years industry experience leading new product market access, health economics and pricing strategy development within medical technology firms. He was Senior Director […]

'